XPENG ($XPEV) posted quarterly earnings results on Tuesday, August 19th. The company reported earnings of -$0.50 per share, beating estimates of -$0.77 by $0.26. The company also reported revenue of $18,317,272,204, missing estimates of $18,889,513,762 by $-572,241,558.
You can see Quiver Quantitative's $XPEV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
XPENG Hedge Fund Activity
We have seen 123 institutional investors add shares of XPENG stock to their portfolio, and 114 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TMT GENERAL PARTNER LTD removed 7,193,000 shares (-22.0%) from their portfolio in Q2 2025, for an estimated $128,610,840
- GOLDMAN SACHS GROUP INC added 3,782,646 shares (+309.9%) to their portfolio in Q2 2025, for an estimated $67,633,710
- MILLENNIUM MANAGEMENT LLC removed 3,008,139 shares (-88.8%) from their portfolio in Q2 2025, for an estimated $53,785,525
- BNP PARIBAS FINANCIAL MARKETS removed 2,126,368 shares (-40.1%) from their portfolio in Q2 2025, for an estimated $38,019,459
- VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 1,866,538 shares (-76.4%) from their portfolio in Q2 2025, for an estimated $33,373,699
- D. E. SHAW & CO., INC. removed 1,783,552 shares (-26.9%) from their portfolio in Q2 2025, for an estimated $31,889,909
- OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) removed 1,759,750 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $36,462,020
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
XPENG Analyst Ratings
Wall Street analysts have issued reports on $XPEV in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Macquarie issued a "Outperform" rating on 05/22/2025
- Barclays issued a "Underweight" rating on 03/20/2025
- JP Morgan issued a "Overweight" rating on 03/19/2025
- B of A Securities issued a "Buy" rating on 03/19/2025
- Citigroup issued a "Buy" rating on 03/10/2025
To track analyst ratings and price targets for XPENG, check out Quiver Quantitative's $XPEV forecast page.
XPENG Price Targets
Multiple analysts have issued price targets for $XPEV recently. We have seen 6 analysts offer price targets for $XPEV in the last 6 months, with a median target of $26.0.
Here are some recent targets:
- Eugene Hsiao from Macquarie set a target price of $25.0 on 08/15/2025
- Jiong Shao from Barclays set a target price of $20.0 on 03/20/2025
- Nick Lai from JP Morgan set a target price of $31.0 on 03/19/2025
- Ming Hsun Lee from B of A Securities set a target price of $27.0 on 03/19/2025
- Jeff Chung from Citigroup set a target price of $29.0 on 03/10/2025
- Paul Gong from UBS set a target price of $18.0 on 02/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
